TheProfitWatch

ACLX - Arcellx, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
89.63 0.94 (1.05%) 0.18 (0.2%) 0.08 (0.09%) -0.82 (-0.89%) --- 0.94 (1.05%) --- ---

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.94
Diluted EPS:
-0.94
Basic P/E:
-96.3511
Diluted P/E:
-96.3511
RSI(14) 1m:
44.41
VWAP:
90.48
RVol:

Events

Period Kind Movement Occurred At

Related News